All recalls
Every recall from CPSC, FDA, USDA and NHTSA, newest first. Each one links to the agency's official notice. Looking for one product? Check a product.
2,237 recalls ยท page 31 of 45
-
Class IIofficial
RemedyRepack Inc. recalls Duloxetine Delayed-Release CapsulesCGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.
-
Class IIofficial
AvKARE recalls Cinacalcet TabletsCGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.
-
Class IIofficial
AvKARE recalls Cinacalcet TabletsCGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.
-
Class IIofficial
AvKARE recalls Cinacalcet TabletsCGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.
-
Class IIofficial
Curium US, LLC recalls Kit for the Preparation of Technetium Tc 99m Sestamibi InjectionLack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the product
-
Class IIofficial
Macleods Pharmaceuticals Ltd recalls Olanzapine TabletsFailed Impurities/Degradation Specifications
-
Class IIofficial
Generitech Corporation recalls 10 Irregular PigmentationCGMP Deviations: Inconsistency in the water systems.
-
Class IIIofficial
Dr. Reddy's Laboratories, Inc. recalls Javygtor (sapropterin dihydrochloride) Tablets 100mgFailed Impurities/Degradation Specifications
-
Class IIofficial
Provepharm Inc. recalls Dihydroergotamine Mesylate InjectionDiscoloration
-
Class IIofficial
Apothecus Pharmaceutical Corp. recalls VCFCGMP deviations: out of specifications for assay
-
Class IIofficial
Jubilant Draximage Inc., dba Jubilant Radiopharma recalls Kit for the Preparation of Technetium Tc 99m Sulfur Colloid InjectionFailed Stability Specifications
-
Class IIofficial
Rising Pharma Holding, Inc. recalls Duloxetine Delayed-Release Capsules USPCGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit
-
Class IIofficial
Rising Pharma Holding, Inc. recalls Duloxetine Delayed-Release Capsules USPCGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit
-
Class IIofficial
Rising Pharma Holding, Inc. recalls Duloxetine DR Capsules USP 60 mgCGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit
-
Class IIofficial
Mylan Institutional, Inc. recalls Levothyroxine Sodium TabletsSubpotent and Superpotent Drug
-
Class IIofficial
Mylan Institutional, Inc. recalls Levothyroxine Sodium TabletsSubpotent and Superpotent Drug
-
Class IIofficial
Mylan Institutional, Inc. recalls Levothyroxine Sodium TabletsSubpotent and Superpotent Drug
-
Class IIofficial
Mylan Institutional, Inc. recalls Levothyroxine Sodium TabletsSubpotent and Superpotent Drug
-
Class IIofficial
Mylan Institutional, Inc. recalls Levothyroxine Sodium TabletsSubpotent and Superpotent Drug
-
Class IIofficial
Mylan Institutional, Inc. recalls Levothyroxine Sodium TabletsSubpotent and Superpotent Drug
-
Class IIofficial
Viatris Inc recalls Levothyroxine Sodium Tablets USPSuperpotent Drug and Subpotent Drug: potency failures obtained
-
Class IIofficial
Viatris Inc recalls Levothyroxine Sodium Tablets USPSuperpotent Drug and Subpotent Drug: potency failures obtained
-
Class IIofficial
Viatris Inc recalls Levothyroxine Sodium Tablets USPSuperpotent Drug and Subpotent Drug: potency failures obtained
-
Class IIofficial
Viatris Inc recalls Levothyroxine Sodium Tablets USPSuperpotent Drug and Subpotent Drug: potency failures obtained
-
Class IIofficial
Viatris Inc recalls Levothyroxine Sodium Tablets USPSuperpotent Drug and Subpotent Drug: potency failures obtained
-
Class IIofficial
Viatris Inc recalls Levothyroxine Sodium Tablets USPSuperpotent Drug and Subpotent Drug: potency failures obtained
-
Class IIofficial
Viatris Inc recalls Levothyroxine Sodium Tablets USPSuperpotent Drug and Subpotent Drug: potency failures obtained
-
Class IIofficial
Viatris Inc recalls Levothyroxine Sodium Tablets USPSuperpotent Drug and Subpotent Drug: potency failures obtained
-
Class IIofficial
Viatris Inc recalls Levothyroxine Sodium Tablets USPSuperpotent Drug and Subpotent Drug: potency failures obtained
-
Class IIofficial
Viatris Inc recalls Levothyroxine Sodium Tablets USPSuperpotent Drug and Subpotent Drug: potency failures obtained
-
Class IIofficial
Viatris Inc recalls Levothyroxine Sodium Tablets USPSuperpotent Drug and Subpotent Drug: potency failures obtained
-
Class Iofficial
Endo USA, Inc. recalls Clonazepam Orally Disintegrating TabletLabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
-
Class Iofficial
Endo USA, Inc. recalls Clonazepam Orally Disintegrating TabletsLabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
-
Class Iofficial
Endo USA, Inc. recalls Clonazepam Orally Disintegrating TabletsLabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
-
Class Iofficial
Endo USA, Inc. recalls Clonazepam Orally Disintegrating TabletsLabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
-
Class IIofficial
Evaric Pharmaceuticals Inc. recalls Lisinopril TabletsPresence of Foreign Object: A pharmacist discovered a metal fragment embedded in a lisinopril 10 mg tablet.
-
Class IIofficial
Amerisource Health Services LLC recalls Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit
-
Class IIofficial
Amerisource Health Services LLC recalls Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit
-
Class IIofficial
Amerisource Health Services LLC recalls Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit
-
Class IIIofficial
Zydus Pharmaceuticals (USA) Inc recalls Esomeprazole Magnesium for Delayed-Release Oral Suspension 40 mgLabeling: Not Elsewhere Classified - Wrong NDC number
-
Class IIofficial
LNK International, Inc. recalls Kirkland Severe Cold & Flu Plus Congestion: Day - 112 coated caplets blister pack; (Acetaminophen 325mgCGMP Deviations: Released product should have been rejected.
-
Class IIofficial
Keystone Industries recalls GelatoCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.
-
Class IIofficial
Keystone Industries recalls M&S Dental Supply Co LLC.CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.
-
Class IIofficial
Keystone Industries recalls PrimoCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.
-
Class IIofficial
Keystone Industries recalls Dental CityCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.
-
Class IIofficial
Keystone Industries recalls Patterson DentalCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.
-
Class IIofficial
Keystone Industries recalls Health-TecCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.
-
Class IIofficial
Keystone Industries recalls BurkhartCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.
-
Class IIofficial
Keystone Industries recalls Pearson QualityCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.
-
Class IIofficial
Keystone Industries recalls safcoCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.